Cart
sales@molnova.com
Benzylurea
CAS No. 538-32-9
Benzylurea ( 1-Benzylurea; AI3-61350; Benzylcarbamide; Benzylurea; N-Benzylurea; Phenylmethylurea; )
Catalog No. M27376 CAS No. 538-32-9
Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzylurea
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
-
DescriptionBenzylurea competitively inhibits dehydrogenase/cytokinin oxidase.
-
Synonyms1-Benzylurea; AI3-61350; Benzylcarbamide; Benzylurea; N-Benzylurea; Phenylmethylurea;
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number538-32-9
-
Formula Weight150.2
-
Molecular FormulaC8H10N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC(=O)NCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamamuro D, Uchida R, Ohtawa M, Arima S, Futamura Y, Katane M, Homma H, Nagamitsu T, Osada H, Tomoda H. Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives. Bioorg Med Chem Lett. 2015 Jan 15;25(2):313-6. doi: 10.1016/j.bmcl.2014.11.042. Epub 2014 Nov 22. PubMed PMID: 25488842.
molnova catalog
related products
-
Glycerol Tridecanoat...
Glycerol Tridecanoate is also known as triacylglycerols or triacylglycerides. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins which deliver the fatty acids to and from fat cells among other functions. Various tissues can release free fatty acids and take them up as a source of energy.
-
Hydroxyamphetamine
Hydroxyamphetamine is an indirect-acting sympathomimetic amine with adrenergic property.
-
Ginsenoside C-K
Ginsenoside C-K is a bacterial metabolite of G-Rb1 exhibiting anti-inflammatory effects by reducing iNOS and COX-2.
